[Diode laser photocoagulation of retinopathy of prematurity]

A Galván Ledesma1, C Morales Guillén, M T Pastor Ramos

  • 1Servicio de Oftalmología, Hospital Virgen del Rocío, Sevilla, España. antoniogalvanledesma@hotmail.com

Insights

Diode laser photocoagulation for retinopathy of prematurity (ROP) shows excellent anatomical outcomes. However, prematurity remains a significant cause of infant visual impairment due to associated neurological issues.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Pediatric Surgery

Context:

  • Retinopathy of prematurity (ROP) is a leading cause of visual impairment in premature infants.
  • Early detection and treatment are crucial for managing ROP.
  • Diode laser photocoagulation is a standard treatment modality for ROP.

Purpose:

  • To evaluate the effectiveness of diode laser photocoagulation in treating retinopathy of prematurity.
  • To analyze anatomical and functional outcomes of ROP treatment.
  • To identify factors influencing treatment success and complications.

Summary:

  • A retrospective study analyzed 147 eyes of premature infants treated for ROP between 2004-2008.
  • 96.5% of eyes achieved good anatomical results; 84.85% showed good functional results after 9 months.
  • Pre-threshold ROP predominated (84.35%); poor outcomes were linked to neurological diseases and intraventricular hemorrhages.

Impact:

  • Diode laser photocoagulation provides highly effective anatomical results for ROP when timely intervention occurs.
  • Neurological disturbances associated with prematurity significantly impact long-term visual function.
  • This study highlights the importance of comprehensive care for premature infants with ROP, addressing both ocular and neurological aspects.
Abstract